Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
J&J picks the inaugural class for its Bay Area biotech incubator
Fierce Biotech
Tue, 03/3/15 - 09:41 am
Tags:
JNJ
,
biotech
,
JLabs
Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis
Yahoo
Mon, 03/2/15 - 08:12 am
Tags:
JNJ
,
Cardinal Health
,
Cordis
,
M&A
Who Might Buy Puma Biotechnology?
Barron's
Fri, 02/27/15 - 02:00 pm
Tags:
Puma Biotechnology
,
M&A
,
Gilead Sciences
,
JNJ
,
Sanofi
FDA postpones key hearing on biosimilar copy of blockbuster drug
Yahoo/Reuters
Thu, 02/26/15 - 09:55 am
Tags:
FDA
,
biosimilars
,
Rensima
,
Remicade
,
JNJ
,
rheumatoid arthritis
,
Crohn's Disease
,
Hospira
,
Celltrion
South Carolina court orders J&J to pay $136 mln in Risperdal case
Yahoo/Reuters
Thu, 02/26/15 - 09:52 am
Tags:
South Carolina
,
JNJ
,
Risperdal
Pharmacyclics mulls sale; J&J, Novartis interested - Bloomberg
Yahoo/Reuters
Wed, 02/25/15 - 04:27 pm
Tags:
Pharmacyclics
,
JNJ
,
Novartis
,
M&A
Johnson & Johnson Loses Trial Over Risperdal And Male Breasts
WSJ/Pharmalot
Wed, 02/25/15 - 08:34 am
Tags:
JNJ
,
Risperdal
,
lawsuits
J&J Hid Risperdal Risks of Male Breast Development, Jury Told
Bloomberg
Mon, 02/23/15 - 09:50 am
Tags:
JNJ
,
Risperdal
Johnson & Johnson reportedly in talks to sell its Cordis unit; Cardinal Health is rumored to be the leading bidder
Bidness Etc.
Mon, 02/23/15 - 08:45 am
Tags:
JNJ
,
Cordis
,
devices
,
M&A
,
Cardinal Health
Will Boston Scientific Corporation (BSX) Learn From Its Guidant Mishap?
Bidness Etc.
Thu, 02/19/15 - 08:27 am
Tags:
Boston Scientific
,
Guidant
,
JNJ
,
devices
Boston Scientific to pay J&J $600 million to settle Guidant suit
Mass Device
Wed, 02/18/15 - 08:27 am
Tags:
Boston Scientific
,
devices
,
JNJ
,
Guidant
Pelvic Mesh lawsuits: J&J drops claim that women were asked to lie for payouts
Mass Device
Wed, 02/18/15 - 08:17 am
Tags:
JNJ
,
pelvic mesh
,
devices
J&J-Pharmacyclics drug shows potential in high-risk leukemia patients
Yahoo/Reuters
Tue, 02/17/15 - 12:46 pm
Tags:
JNJ
,
Pharmacyclics
,
Imbruvica
,
chronic lymphocytic leukemia
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Tags:
Humira
,
Sovaldi
,
Remicade
,
Enbrel
,
Lantus
,
Rituxan
,
Advair
,
Avastin
,
Herceptin
,
Januvia
,
Merck
,
AbbVie
,
Gilead Sciences
,
JNJ
,
Amgen
,
Pfizer
,
Sanofi
,
Roche
,
GSK
Johnson & Johnson aim to spot who'll get a disease
The News Star
Sun, 02/15/15 - 11:57 am
Tags:
JNJ
Johnson & Johnson Faces Pressure From U.S. Patent Office
Yahoo/Benzinga
Sat, 02/14/15 - 10:36 am
Tags:
JNJ
,
patents
,
Remicade
J&J's R&D group crafts 3 new platforms to guide global drug development
Fierce Biotech
Thu, 02/12/15 - 09:36 am
Tags:
JNJ
,
R&D
J&J drops bid to probe plaintiff solicitation in mesh cases
Yahoo/Reuters
Thu, 02/12/15 - 09:10 am
Tags:
JNJ
,
pelvic mesh
J&J's DePuy Synthes buys Olive Medical for hi-def surgery system
Mass Device
Wed, 02/11/15 - 09:00 am
Tags:
devices
,
JNJ
,
DePuy Synthes Spine
,
Olive Medical
,
M&A
Competition to J&J's Remicade looms in U.S. as biosimilar conquers new markets
Fierce Biotech
Wed, 02/11/15 - 08:57 am
Tags:
JNJ
,
Remicade
,
biosimilars
,
FDA
,
Celltrion
,
Remsima
Pages
« first
‹ previous
…
99
100
101
102
103
104
105
106
107
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.